{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:01:04Z","timestamp":1792674064383,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.eururo.2012.08.061","type":"journal-article","created":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T01:30:36Z","timestamp":1346808636000},"page":"36-44","source":"Crossref","is-referenced-by-count":132,"title":["ICUD-EAU International Consultation on Bladder Cancer 2012: Non\u2013Muscle-Invasive Urothelial Carcinoma of the Bladder"],"prefix":"10.1016","volume":"63","author":[{"given":"Maximilian","family":"Burger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"Oosterlinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badrinath","family":"Konety","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurdur","family":"Gudjonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Pruthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Soloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Solsona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sved","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Babjuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio A.","family":"Brausi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Comperat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Dinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Th\u00fcrof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Alfred","family":"Witjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2012.08.061_bib0005","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.eururo.2007.07.011","article-title":"It is time to abandon the \u201csuperficial\u201d in bladder cancer","volume":"52","author":"Soloway","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0010","unstructured":"Phillips B, Ball C, Sackett D, et al. Oxford Centre for Evidence-based Medicine\u2014levels of evidence. March 2009. Centre for Evidence-based Medicine Web site. http:\/\/www.cebm.net\/index.aspx?o=1025."},{"key":"10.1016\/j.eururo.2012.08.061_bib0255","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2012.09.063","article-title":"ICUD-EAU International Consultation on Bladder Cancer 2012: pathology","volume":"63","author":"Amin","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0020","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.eururo.2012.03.018","article-title":"The importance of transurethral resection in managing patients with urothelial cancer in the bladder: proposal for a transurethral resection of bladder tumor checklist","volume":"61","author":"Pan","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0025","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.eururo.2009.11.041","article-title":"Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies","volume":"57","author":"Kausch","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.juro.2012.03.007","article-title":"Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy","volume":"188","author":"Grossman","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0035","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.eururo.2010.01.025","article-title":"Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations","volume":"57","author":"Witjes","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0040","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1464-410X.2010.09547.x","article-title":"Reduced bladder tumour recurrence rate associated with narrow-band imaging surveillance cystoscopy","volume":"107","author":"Herr","year":"2011","journal-title":"BJU Int"},{"issue":"Suppl 1","key":"10.1016\/j.eururo.2012.08.061_bib0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.urology.2005.06.135","article-title":"High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder","volume":"66","author":"Sylvester","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2012.08.061_bib0050","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.eururo.2011.05.053","article-title":"Urine markers for detection and surveillance of non-muscle-invasive bladder cancer","volume":"60","author":"Tilki","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0260","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.eururo.2012.09.057","article-title":"ICUD-EAU International Consultation on Bladder Cancer 2012: screening, diagnosis, and molecular markers","volume":"63","author":"Kamat","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0060","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.urology.2010.04.069","article-title":"Point: routine use of postoperative intravesical chemotherapy after TURBT\u2014should it be done?","volume":"76","author":"Soloway","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2012.08.061_bib0065","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0022-5347(17)55976-5","article-title":"Rationale for intensive intravesical chemotherapy for superficial bladder cancer","volume":"123","author":"Soloway","year":"1980","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0070","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1097\/01.ju.0000125486.92260.b2","article-title":"A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials","volume":"171","author":"Sylvester","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0075","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00345-011-0691-2","article-title":"Long-term experience with early single mitomycin C instillations in patients with low-risk non-muscle-invasive bladder cancer: prospective, single-centre randomised trial","volume":"29","author":"De Nunzio","year":"2011","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0080","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.eururo.2009.01.006","article-title":"Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? the results of a prospective randomised multicentre study","volume":"55","author":"Gudjonsson","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0085","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.eururo.2009.06.010","article-title":"Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre study","volume":"56","author":"Bohle","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0090","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/01.ju.0000169424.79702.6d","article-title":"Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor","volume":"174","author":"Palou","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0095","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.juro.2008.10.168","article-title":"Predictors of upper tract urothelial cell carcinoma after primary bladder cancer: a population based analysis","volume":"181","author":"Wright","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0100","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0105","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1464-4096.2001.02396.x","article-title":"Does cystoscopy correlate with the histology of recurrent papillary tumours of the bladder?","volume":"88","author":"Herr","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2012.08.061_bib0110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.urolonc.2005.07.005","article-title":"Expectant treatment of small, recurrent, low-grade, noninvasive tumors of the urinary bladder","volume":"24","author":"Soloway","year":"2006","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0115","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0022-5347(01)67608-0","volume":"153","author":"Bouffioux","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0120","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/jnci\/93.8.597","article-title":"Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial","volume":"93","author":"Au","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2012.08.061_bib0125","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1464-410X.2011.10880.x","article-title":"Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review","volume":"109","author":"Shelley","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2012.08.061_bib0130","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1464-410X.2003.04655.x","article-title":"Intravesical bacillus Calmette-Guerin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials","volume":"93","author":"Shelley","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2012.08.061_bib0135","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.eururo.2009.04.038","article-title":"An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guerin for non-muscle-invasive bladder cancer","volume":"56","author":"Malmstrom","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0140","series-title":"World Health Organization classification of tumors pathology and genetics: tumors of the urinary system and male genital organs","article-title":"Non-invasive urothelial neoplasias: WHO classification of non invasive papillary urothelial tumors","author":"Sauter","year":"2004"},{"key":"10.1016\/j.eururo.2012.08.061_bib0145","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1097\/01.ju.0000181799.81119.fc","article-title":"Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy","volume":"174","author":"Herr","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0150","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.urology.2009.08.082","article-title":"\u201cComplete transurethral resection of bladder tumor\u201d: are the guidelines being followed?","volume":"75","author":"Adiyat","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2012.08.061_bib0155","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.eururo.2009.12.024","volume":"57","author":"Sylvester","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0160","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.eururo.2009.04.009","volume":"56","author":"Jarvinen","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0165","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.juro.2010.01.025","article-title":"Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients","volume":"183","author":"Tilki","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0170","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.ju.0000162059.64886.1c","article-title":"Bacillus Calmette-Guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials","volume":"174","author":"Sylvester","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0175","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.eururo.2003.10.006","article-title":"Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy","volume":"45","author":"Schrier","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0180","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.eururo.2009.07.005","article-title":"Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer","volume":"56","author":"Dalbagni","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0185","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eururo.2009.06.028","article-title":"Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy","volume":"56","author":"van Rhijn","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0190","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0195","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0022-5347(05)64044-X","article-title":"A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival","volume":"169","author":"Shahin","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0200","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.eururo.2007.06.030","article-title":"Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach?","volume":"53","author":"Denzinger","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0205","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1097\/01.ju.0000062605.92268.c6","article-title":"Defining bacillus Calmette-Guerin refractory superficial bladder tumors","volume":"169","author":"Herr","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0210","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.eururo.2009.09.024","article-title":"Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort","volume":"57","author":"Fritsche","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0215","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.urology.2007.09.050","article-title":"Impact of previous bacille Calmette-Guerin failure pattern on subsequent response to bacille Calmette-Guerin plus interferon intravesical therapy","volume":"71","author":"Gallagher","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2012.08.061_bib0220","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/cncr.24914","article-title":"Gemcitabine versus bacille Calmette-Guerin after initial bacille Calmette-Guerin failure in non-muscle-invasive bladder cancer: a multicenter prospective randomized trial","volume":"116","author":"Di Lorenzo","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2012.08.061_bib0225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.eururo.2009.09.038","article-title":"Bacillus Calmette-Guerin is superior to a combination of epirubicin and interferon-alpha2b in the intravesical treatment of patients with stage T1 urinary bladder cancer: a prospective, randomized, Nordic study","volume":"57","author":"Duchek","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0230","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.juro.2009.06.017","article-title":"Combined thermo-chemotherapy for recurrent bladder cancer after bacillus Calmette-Guerin","volume":"182","author":"Nativ","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0235","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.eururo.2011.03.017","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update","volume":"59","author":"Babjuk","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0240","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.eururo.2011.03.023","article-title":"Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines","volume":"59","author":"Stenzl","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0245","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.eururo.2011.05.045","article-title":"Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review","volume":"60","author":"van den Bosch","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.061_bib0250","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.eururo.2011.11.052","article-title":"A plea for long-term surveillance in bacillus Calmette-Guerin-treated non-muscle-invasive bladder cancer","volume":"61","author":"Meijer","year":"2012","journal-title":"Eur Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283812010147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283812010147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T11:31:03Z","timestamp":1562153463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283812010147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0302283812010147"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2012.08.061","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}